Table 3.
Determinants of fatigue as measured with the MFI-20 summary score
| Determinant | OR (95% CI) |
|---|---|
| Sex | 0.9 (0.5−1.7), P = 0.732 |
| Age | 1.0 (0.97−1.02), P = 0.576 |
| Educational level | |
| Low (reference) | – |
| Intermediate | 0.9 (0.5−1.7), P = 0.716 |
| High | 0.3 (0.2−0.7), P = 0.005 |
| Number of comorbidities | 1.6 (1.3−1.9), P < 0.001 |
| Tumor location | |
| Multiple locations (reference) | – |
| Cerebral convexity | 1.2 (0.4−3.1), P = 0.738 |
| Skull base | 0.6 (0.2−1.6), P = 0.331 |
| Falx | 1.0 (0.3−3.0), P = 0.988 |
| Other | 1.0 (0.3−3.5), P = 0.939 |
| Tumor size | |
| No tumor (complete resection) (reference) | – |
| <40 mm | 1.2 (0.6−2.3), P = 0.581 |
| ≥40 mm | 0.9 (0.2−4.8), P = 0.867 |
| WHO grade | |
| 1 (reference) | – |
| 2 | 2.2 (1.0−5.2), P = 0.064 |
| Unknown/not clear | 0.4 (0.1−3.7), P = 0.453 |
| Seizures in the past 3 months | 1.1 (0.9−1.5), P = 0.285 |
| Underwent resection | 1.7 (0.5−5.9), P = 0.373 |
| Underwent radiotherapy | 2.4 (1.2−4.8), P = 0.019 |
| Complications after resection | 3.6 (1.8−7.0), P < 0.001 |
OR, odds ratio, CI, confidence interval.
Statistically significant differences are outlined in bold.